| Liu, Wei |
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction |
|
|
| Terminated | 3 | 535 | Europe, Canada, Japan, US, RoW | BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo | Remedy Pharmaceuticals, Inc. | Brain Edema, Stroke, Acute | 08/23 | 08/23 | | |
| Active, not recruiting | 3 | 408 | RoW | KN046, placebo | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Advanced Pancreatic Ductal Adenocarcinoma | 04/24 | 08/24 | | |
NCT06434467: The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma |
|
|
| Not yet recruiting | 3 | 83 | RoW | Nelarabine injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | T-lymphoblastic Leukemia, T-lymphoblastic Lymphoma | 12/25 | 05/26 | | |
| Completed | 2 | 3 | RoW | ICP-022 | Beijing InnoCare Pharma Tech Co., Ltd. | Diffuse Large B Cell Lymphoma | 11/21 | 12/21 | | |
NCT05346146: A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer. |
|
|
| Recruiting | 2 | 20 | RoW | Sintilimab; Gemcitabine; Albumin-paclitaxel | RenJi Hospital, Innovent Biologics (Suzhou) Co. Ltd. | Unresectable Locally Advanced Pancreatic Cancer | 07/23 | 07/24 | | |
NCT05997602: To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH |
|
|
| Recruiting | 2 | 56 | RoW | FCN-159 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Langerhans Cell Histiocytosis, LCH | 07/24 | 07/26 | | |
NCT04690192: CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma |
|
|
| Active, not recruiting | 1/2 | 20 | RoW | CNCT19, Gemcitabine Injection, busulfan, Melphalan Injection | Zou Dehui, Juventas Cell Therapy Ltd. | Large B-cell Lymphoma | 12/23 | 12/24 | | |
NCT04464551: The Absorption, Metabolism and Excretion of [14C]D-0316 in Human |
|
|
| Active, not recruiting | 1 | 4 | RoW | [14C]D-0316 suspension | Betta Pharmaceuticals Co., Ltd. | Advanced or Metastatic Non-small Cell Lung | 08/21 | 08/21 | | |
NCT04696705: Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients |
|
|
| Recruiting | 1 | 10 | RoW | Ex-vivo expanded allogeneic γδT cells | Institute of Hematology & Blood Diseases Hospital, Beijing GD Initiative Cell Therapy Technology Co., Ltd., Chinese Academy of Medical Sciences | Non-Hodgkin's Lymphoma (NHL), Peripheral T Cell Lymphoma (PTCL) | 12/21 | 12/23 | | |
| Active, not recruiting | 1 | 18 | RoW | Liposomal Mitoxantrone Hydrochloride dose level 1, Liposomal Mitoxantrone Hydrochloride dose level 2, Liposomal Mitoxantrone Hydrochloride dose level 3, Liposomal Mitoxantrone Hydrochloride dose level 4 | Institute of Hematology & Blood Diseases Hospital, China, CSPC Ouyi Pharmaceutical Co., Ltd. | Non Hodgkin Lymphoma | 12/23 | 12/25 | | |
NCT05318963: Targeting CD19/CD20/CD22 Triple-targeted Cell in Patients With Relapsed/Refractory B-cell Lymphoma |
|
|
| Recruiting | 1 | 34 | RoW | LCAR-AIO cells product | Qiu Lugui, Nanjing Legend Biotech Co. | B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory | 06/24 | 06/26 | | |
NCT04853238: Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China |
|
|
| Completed | N/A | 1507 | RoW | Prospective observational cohort study | GlaxoSmithKline | Pulmonary Disease, Chronic Obstructive | 11/22 | 02/23 | | |
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus |
|
|
| Recruiting | N/A | 184 | RoW | Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter | Shanghai Bluesail Boyuan Medical Technology Co., Ltd. | Coronary Artery Disease, Intravascular Lithotripsy | 12/24 | 09/25 | | |
